Get the Stockscreener App
42.83
5.41%
-2.45
After Hours:
42.85
0.02
+0.05%
Vaxcyte Inc stock is traded at $42.83, with a volume of 2.03M.
It is down -5.41% in the last 24 hours and up +0.40% over the past month.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
See More
Previous Close:
$45.28
Open:
$45.13
24h Volume:
2.03M
Relative Volume:
1.19
Market Cap:
$5.56B
Revenue:
-
Net Income/Loss:
$-507.65M
P/E Ratio:
-9.3109
EPS:
-4.6
Net Cash Flow:
$-616.24M
1W Performance:
-3.90%
1M Performance:
+0.40%
6M Performance:
+21.02%
1Y Performance:
-60.08%
1-Day Range:
$42.00
$45.99
1-Week Range:
$42.00
$45.99
52-Week Range:
$27.66
$116.00
Vaxcyte Inc Stock (PCVX) Company Profile
Name
Vaxcyte Inc
Sector
Industry
Phone
650-837-0111
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
42.83 | 5.88B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-25 | Initiated | Goldman | Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-24 | Initiated | Goldman | Buy |
| Dec-07-23 | Initiated | Mizuho | Buy |
| Apr-18-23 | Initiated | TD Cowen | Outperform |
| Jan-03-23 | Reiterated | Needham | Buy |
| Dec-15-22 | Initiated | Guggenheim | Buy |
| Nov-17-22 | Initiated | BTIG Research | Buy |
| Dec-29-21 | Resumed | Jefferies | Buy |
| Jun-24-21 | Resumed | Jefferies | Buy |
| Jul-07-20 | Initiated | BofA Securities | Buy |
| Jul-07-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-07-20 | Initiated | Needham | Buy |
View All
Vaxcyte Inc Stock (PCVX) Latest News
Will Vaxcyte Inc. benefit from macro trendsWeekly Trade Review & Daily Profit Maximizing Tips - newser.com
When is the best time to exit Vaxcyte Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
What margin trends mean for Vaxcyte Inc. stockWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgradesJuly 2025 Movers & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Vaxcyte Inc. analyzedJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Will Vaxcyte Inc. stock continue upward momentumGDP Growth & Community Verified Trade Signals - newser.com
Is Vaxcyte Inc. (5VA) stock a top hedge fund pickWeekly Investment Report & Verified Momentum Watchlists - newser.com
Should you wait for a breakout in Vaxcyte Inc.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
How Vaxcyte Inc. stock reacts to Fed rate cuts2025 AllTime Highs & Stepwise Trade Signal Implementation - newser.com
Will Vaxcyte Inc. stock benefit from commodity prices2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Quantitative breakdown of Vaxcyte Inc. recent move2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Is Vaxcyte Inc 5VA a good long term investmentFlag and Pennant Patterns & Capital Planning and Optimization - earlytimes.in
Has Vaxcyte Inc. found a price floor2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com
Vaxcyte, Inc. $PCVX Position Raised by State of New Jersey Common Pension Fund D - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is Vaxcyte Inc. stock poised for growthEarnings Beat & Community Supported Trade Ideas - newser.com
Identifying reversal signals in Vaxcyte Inc.Earnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Vaxcyte, Inc. $PCVX Shares Purchased by Jennison Associates LLC - MarketBeat
Will Vaxcyte Inc. stock outperform Nasdaq indexJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Does Vaxcyte Inc. show high probability of rebound2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Using data tools to time your Vaxcyte Inc. exitBond Market & Fast Entry and Exit Trade Plans - newser.com
Is Vaxcyte Inc. (5VA) stock protected from inflationPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Gillette India The best an Investor can getVolume Spike Alerts & Ride the Wave of Market-Beating Growth - earlytimes.in
Is Vaxcyte Inc a good long term investmentPrice Volatility Patterns & Superior Capital Appreciation - earlytimes.in
What moving averages say about Vaxcyte Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Vaxcyte (PCVX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Vaxcyte Inc Stock (PCVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):